Cercar
01/10/2021
Endoscopic exploration directly impacts clinical decision making in the management of patients with suspected upper tract urothelial carcinoma following radical cystectomy
Aumatell, J, Huguet, J, Subiela, JD, Gaya, JM, Faba, OR, Territo, A, Palou, J, Breda, A. Endoscopic exploration directly impacts clinical decision making in the management of patients with suspected upper tract urothelial carcinoma following radical cystectomy. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2021; 39(10)DOI:10.1016/j.urolonc.2021.03.002. PMID:33863619. IF:2.954(Q3/6D).
01/10/2021
From the Hippocratic oath to the stone center: how to deal with stone disease
Esperto, F, Pietropaolo, A, Emiliani, E, De Conninck, V, Tailly, T, Keller, EX, Talso, M, Tonyali, S, Sener, ET, Zeeshan Hameed, BM, Usai, P, Di Paola, V, Papalia, R, Scarpa, RM. From the Hippocratic oath to the stone center: how to deal with stone disease. Minerva Urology And Nephrology. 2021; 73(5)DOI:10.23736/S2724-6051.21.04722-4. PMID:34847649. IF:5.214(Q1/3D).
01/10/2021
Non-muscle-invasive bladder cancer: An overview of potential new treatment options
Shore, ND, Redorta, JP, Robert, G, Hutson, TE, Cesari, R, Hariharan, S, Faba, G, Briganti, A, Steinberg, GD. Non-muscle-invasive bladder cancer: An overview of potential new treatment options. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2021; 39(10)DOI:10.1016/j.urolonc.2021.05.015. PMID:34167873. IF:2.954(Q3/6D).
01/10/2021
Exploratory analysis on the usage of Pi-score algorithm over endoscopic stone treatment step 1 protocol
Veneziano, D, Patruno, G, Talso, M, Tokas, T, Proietti, S, Porreca, A, Kamphuis, G, Biyani, S, Emiliani, E, Cepeda Delgado, M, de Mar Perez, LM, Miano, R, Ferretti, S, Macchione, N, Kallidonis, P, Montanari, E, Tripepi, G, Ploumidis, A, Cacciamani, G, Lima, E, Somani, B. Exploratory analysis on the usage of Pi-score algorithm over endoscopic stone treatment step 1 protocol. Minerva Urology And Nephrology. 2021; 73(5)DOI:10.23736/S2724-6051.20.03747-9. PMID:32748615. IF:5.214(Q1/3D).